AI accelerates drug discovery from decades to months as Isomorphic Labs’ Drug Design Engine pushes beyond Nobel-Level science - Tech Startups

AI accelerates drug discovery from decades to months as Isomorphic Labs’ Drug Design Engine pushes beyond Nobel-Level science - Tech Startups

In 2024, Sir Demis Hassabis and John Jumper were awarded the Nobel Prize in Chemistry for AlphaFold, an AI system that solved a fifty-year problem by predicting protein structures at scale. The achievement felt like a finish line for AI-driven […] The post AI accelerates drug discovery from decades to months as Isomorphic Labs’ Drug Design Engine pushes beyond Nobel-Level science first appeared on Tech Startups.

Isomorphic claims major advance with new AI drug design engine, in 'step change' versus AlphaFold 3

Nearly two years ago, Isomorphic Labs dropped AlphaFold 3, the latest generation of its Nobel Prize-winning, structure-predicting AI model. Now the company claims it has another major advance on its hands. While ...

Google's AI drug discovery spinoff Isomorphic Labs claims major leap beyond AlphaFold 3

Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy for certain drug design predictions. The article Google's AI drug discovery spinoff Isomorphic Labs claims major leap beyond AlphaFold 3 appeared first on The Decoder.

Google's Drug Discovery Arm Isomorphic Labs Doubles Accuracy In Designing Medicines Through A Computer In New Breakthrough

The most visible impact of AI seems to be in coding, but it could also be poised to disrupt other hard sciences. Isomorphic... The post Google’s Drug Discovery Arm Isomorphic Labs Doubles Accuracy In Designing Medicines Through A Computer In New Breakthrough appeared first on OfficeChai.

Isomorphic Labs’ Next‑Gen IsoDDE Engine Advances AI‑Driven Design Of Complex And Hard‑To‑Target Molecules

Isomorphic Labs, a Google DeepMind spin‑off, has presented IsoDDE, described as the most advanced publicly disclosed AI system for computational drug design as of February 2026.  The platform is positioned as a full‑cycle in silico engine that moves beyond the structure‑prediction focus of AlphaFold 3 and aims to address several long‑standing limitations in digital drug‑development workflows.  According to the company, IsoDDE is designed to gene…